tiprankstipranks
Advertisement
Advertisement

LRMR Stock Latest News

Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
RatingsNomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
11d ago
LRMR
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
23d ago
LRMR
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
PremiumRatings
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
24d ago
LRMR
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
PremiumThe Fly
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
24d ago
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
LRMR
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
PremiumCompany AnnouncementsLarimar Advances Nomlabofusp Toward 2026 BLA Submission
1M ago
8K
LRMR
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
Premium
The Fly
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
1M ago
LRMR
Larimar Therapeutics Announces Upsized Public Equity Offering
Premium
Company Announcements
Larimar Therapeutics Announces Upsized Public Equity Offering
1M ago
8K
LRMR
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
PremiumThe Fly
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
2M ago
LRMR
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
PremiumThe Fly
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
2M ago
LRMR
Larimar Therapeutics price target raised to $14 from $12 at Citi
PremiumThe Fly
Larimar Therapeutics price target raised to $14 from $12 at Citi
2M ago
LRMR
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
PremiumThe Fly
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
2M ago
HD
AMD
Larimar Therapeutics announces FDA granted BTD to nomlabofusp
PremiumThe FlyLarimar Therapeutics announces FDA granted BTD to nomlabofusp
2M ago
LRMR
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
Premium
Company Announcements
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
2M ago
8K
LRMR
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
Premium
Company Announcements
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
2M ago
LRMR
Larimar Therapeutics executes preferred stock exchange and amendment
PremiumCompany Announcements
Larimar Therapeutics executes preferred stock exchange and amendment
3M ago
8K
LRMR
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
PremiumCompany Announcements
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
3M ago
8K
LRMR
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
PremiumCompany Announcements
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
4M ago
8K
LRMR
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
PremiumCompany Announcements
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
5M ago
8K
LRMR
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
PremiumCompany AnnouncementsLarimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
5M ago
LRMR
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
Premium
Ratings
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
5M ago
LRMR
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
Premium
Ratings
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
5M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >